Daniele X. Assad-Suzuki
Sao Paulo, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 20 publications
GLP-1 receptor agonists and breast cancer: emerging evidence from prevention to treatment.
Journal: The American journal of medicine
Published: July 23, 2026
Clinical Impact and Clinicopathologic Correlations of Oncotype DX in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Real-World Evidence From a Large Brazilian Cohort (GBECAM 0520).
Journal: JCO oncology practice
Published: March 06, 2026
Neoadjuvant pembrolizumab plus chemotherapy in germline BRCA-mutated early triple-negative breast cancer: a multicenter real-world cohort.
Journal: NPJ breast cancer
Published: February 20, 2026
Treatment patterns and safety of adjuvant therapy after chemoimmunotherapy for early-stage triple-negative breast cancer: real-world data from the Neo-Real/GBECAM 0123 study.
Journal: Breast cancer research and treatment
Published: November 22, 2025
Neoadjuvant pembrolizumab plus chemotherapy in older patients with early-stage triple-negative breast cancer: real-world insights from neo-real/GBECAM-0123.
Journal: NPJ breast cancer
Published: November 02, 2025
Cancer Health Disparities Among Patients With Early-Stage Estrogen Receptor-Positive Breast Cancer: Impact of Public Versus Private Health Care on Diagnosis-to-Treatment Interval in Brazil.
Journal: JCO global oncology
Published: October 08, 2025
Impact of public vs. private insurance coverage on quality of life of women with early-stage estrogen receptor-positive breast cancer.
Journal: Breast cancer research and treatment
Published: September 02, 2025
Safety and efficacy of tiragolumab, atezolizumab and chemotherapy for early-stage or PD-L1-positive advanced triple-negative breast cancer: a phase Ib study.
Journal: ESMO open
Published: July 08, 2025
Non-metastatic breast cancer in older patients in Brazil: Adherence to endocrine therapy, quality of life, and sexual health.
Journal: Journal of geriatric oncology
Published: May 25, 2025
Last Updated: 09/26/2026